Prescription Required
Formulation: Tablet
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Tablet
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Cyklokapron (active ingredient: tranexamic acid) is a prescription antifibrinolytic medication that helps reduce or prevent excessive bleeding. It works by helping blood clots remain stable so they are not broken down too quickly.
In the current U.S. prescribing information, Cyklokapron injection is specifically approved for short-term use in people with hemophilia who are undergoing tooth extraction. It is used to reduce or prevent bleeding during and after the procedure and may reduce the amount of clotting-factor replacement therapy needed.
Bleeding Control in People With Hemophilia
Hemophilia is a bleeding disorder in which the blood does not clot normally because certain clotting factors are missing or present at lower levels.
People with hemophilia may have prolonged bleeding after an injury, surgery, or dental procedure.
Cyklokapron can be used around the time of a tooth extraction to help the blood clot remain stable and reduce continued bleeding.
Bleeding During and After Tooth Extraction
Dental procedures can be a particular concern for people with hemophilia because the mouth contains substances that naturally encourage blood clots to break down.
After a tooth is removed, the body forms a clot in the empty socket to stop bleeding and begin healing.
Cyklokapron helps protect this clot from breaking down too quickly. This can reduce bleeding during the procedure and help control bleeding afterward.
According to the U.S. label, Cyklokapron is generally used for a short period of 2 to 8 days around tooth extraction in patients with hemophilia.
Cyklokapron belongs to a group of medicines called antifibrinolytics.
To understand how it works, it helps to understand how the body normally forms and removes blood clots.
The Body Forms a Blood Clot
When a blood vessel is damaged, the body creates a clot to help stop bleeding.
One of the important components of a stable blood clot is fibrin. Fibrin forms a mesh that helps hold the clot together at the site of an injury.
The Body Also Breaks Down Blood Clots
Once a clot is no longer needed, the body gradually breaks it down through a natural process called fibrinolysis.
An inactive protein called plasminogen is converted into an enzyme called plasmin.
Plasmin breaks down fibrin and helps dissolve the clot.
This process is normal and necessary, but if a clot breaks down too quickly, bleeding can continue or restart.
Tranexamic Acid Slows Fibrinolysis
Tranexamic acid helps prevent plasminogen from binding effectively to fibrin.
By interfering with this process, Cyklokapron reduces the breakdown of fibrin within the blood clot.
The result is a more stable clot that can remain in place long enough to help control bleeding.
Cyklokapron Helps Preserve Existing Clots
Cyklokapron does not directly create a blood clot.
Instead, it helps protect a clot that the body has already formed.
This is an important distinction. Cyklokapron supports the body’s natural clotting process by slowing down clot breakdown rather than directly activating the clotting system.
People with hemophilia already have difficulty forming effective blood clots.
Even when clotting-factor replacement therapy helps a clot form, the clot may still be vulnerable to breakdown.
Cyklokapron adds another layer of support by slowing fibrinolysis. For dental extraction, it is used together with appropriate replacement therapy according to the U.S. prescribing information.
Cyklokapron does not replace the missing clotting factor in a person with hemophilia.
Clotting-factor replacement therapy helps correct the underlying clotting-factor deficiency.
Cyklokapron works differently by helping preserve fibrin after a clot has formed.
For this reason, the two treatments may be used together around a dental procedure.
Tranexamic acid is used in other medical situations, but the approved indication depends on the specific formulation, route of administration, and country.
For example, oral tranexamic acid tablets are approved in the U.S. to treat cyclic heavy menstrual bleeding in females of reproductive potential. For people with normal kidney function, the labeled oral regimen is 1,300 mg three times daily for up to 5 days during menstruation.
This oral product should not be confused with Cyklokapron injection.
Tranexamic acid may be used in clinical practice in other settings where reducing bleeding is important. However, these uses should not automatically be listed as approved indications for the U.S. Cyklokapron injection.
The current U.S. Cyklokapron label specifically covers short-term bleeding prevention and reduction in patients with hemophilia during and following tooth extraction.
For its U.S.-approved indication, Cyklokapron is intended for short-term treatment.
It may be given immediately before tooth extraction and then continued after the procedure for 2 to 8 days, depending on the healthcare provider’s treatment plan.
The exact dose and treatment duration depend on factors such as body weight, kidney function, the procedure, and the patient’s bleeding risk.
Cyklokapron helps control bleeding, but it does not cure hemophilia or correct the underlying clotting-factor deficiency.
It is supportive treatment that helps protect blood clots from breaking down prematurely.
Cyklokapron helps reduce bleeding by slowing the breakdown of fibrin in blood clots. For the U.S. Cyklokapron injection product, its labeled use is short-term treatment in patients with hemophilia during and after tooth extraction.
Use Cyklokapron only as directed by your healthcare provider. The appropriate tranexamic acid product, dose, route, and treatment duration depend on the reason it is being used and your individual medical needs.
Tranexamic acid tablets are prescription antifibrinolytic medicines used to reduce cyclic heavy menstrual bleeding in females of reproductive potential. They work by helping blood clots remain stable, which can reduce the amount of blood lost during a menstrual period.
For people with normal kidney function, the usual dose is 1,300 mg three times daily.
Because each tablet commonly contains 650 mg, this means taking:
The total daily dose is 3,900 mg. Treatment should be used for no more than 5 days during each menstrual period.
Tranexamic acid tablets for heavy menstrual bleeding are taken only during your menstrual period.
Start taking the medicine when menstrual bleeding begins, according to your healthcare provider’s instructions. It is not intended to be taken every day throughout the entire month for this indication.
Tranexamic acid tablets can be taken with or without food.
If the medicine causes stomach discomfort, taking it with food may be more comfortable. Try to take your doses at approximately the same times each day while you are using the medication.
Swallow the tablets whole with water.
Do not crush, chew, or break them unless your pharmacist or healthcare provider specifically tells you that your particular product can be altered.
If your prescription calls for three doses each day, space them reasonably throughout your waking hours.
You do not need to take the tablets at exactly the same minute every day, but taking them on a consistent schedule can make it easier to avoid missed or extra doses.
Do not increase the number of tablets, take doses more frequently, or continue treatment for longer than directed.
Taking extra tranexamic acid does not necessarily control bleeding more effectively and may increase the risk of unwanted effects.
For heavy menstrual bleeding, the labeled regimen should not exceed 5 days per menstrual cycle.
Tranexamic acid is cleared mainly through the kidneys.
If your kidneys do not work normally, tranexamic acid can build up in your body. Your healthcare provider may therefore prescribe a lower dose based on your kidney function. The U.S. prescribing information provides reduced dosing schedules for people with elevated serum creatinine levels.
Tell your healthcare provider if you have kidney disease or reduced kidney function before starting treatment.
For oral tranexamic acid tablets used for cyclic heavy menstrual bleeding, the standard adult dose is not normally calculated according to body weight. Instead, dosing is mainly adjusted for kidney function when necessary.
Weight-based dosing applies to some injectable tranexamic acid regimens. For example, the U.S. Cyklokapron injection label uses actual body weight to calculate the dose for patients with hemophilia undergoing tooth extraction.
Before taking tranexamic acid, tell your healthcare provider about all medications and products you use, including prescription medicines, over-the-counter drugs, vitamins, and supplements.
This is particularly important for medicines that may affect blood-clotting risk.
Tell your healthcare provider if you use a combined hormonal contraceptive, such as certain birth control pills, patches, or vaginal rings.
The U.S. prescribing information lists the use of oral tranexamic acid tablets together with combined hormonal contraceptives as contraindicated because both may increase the risk of blood clots.
Your healthcare provider can determine whether a different treatment is appropriate.
If you take a blood thinner or another medication that affects blood clotting, tell your healthcare provider before taking tranexamic acid.
Do not start, stop, or change either medication without professional guidance. The reason for using the blood thinner and the reason for treating bleeding both need to be considered when determining whether tranexamic acid is appropriate.
If you miss a dose, follow the instructions provided with your prescription or ask your pharmacist what to do.
Do not take extra tablets or double your next dose unless your healthcare provider specifically tells you to.
Tranexamic acid is not a hormone and does not prevent menstruation.
Its purpose is to reduce excessive menstrual blood loss. Clinical information for oral tranexamic acid notes that it can substantially reduce the amount of blood lost during a period, but it is not intended to stop the menstrual period completely.
Contact your healthcare provider if your menstrual bleeding remains unusually heavy, becomes worse, or does not improve with treatment.
Heavy or abnormal bleeding can sometimes have an underlying cause that needs further evaluation. The prescribing information recommends excluding endometrial conditions that may contribute to heavy menstrual bleeding before tranexamic acid tablets are prescribed.
The name Cyklokapron can cause confusion in U.S.-focused medication information.
In the current U.S. labeling, Cyklokapron is an intravenous tranexamic acid product, not a tablet. It is indicated for short-term bleeding prevention or reduction in patients with hemophilia during and after tooth extraction.
The regimen of two 650 mg tablets three times daily for up to 5 days applies to oral tranexamic acid tablets used for cyclic heavy menstrual bleeding.
Take tranexamic acid exactly as prescribed. For cyclic heavy menstrual bleeding and normal kidney function, the usual regimen is 1,300 mg three times daily for a maximum of 5 days during menstruation.
Do not take additional tablets or continue treatment longer than recommended. Tell your healthcare provider about kidney problems, hormonal contraceptives, blood thinners, and all other medicines you use before starting treatment.
Cyklokapron (Tranexamic Acid) is available in the following forms and strength:
Tranexamic acid helps prevent blood clots from breaking down too quickly. Because of this effect, it may increase the risk of venous or arterial blood clots in some people.
Tell your healthcare provider if you have a history of deep vein thrombosis (DVT), pulmonary embolism, stroke, heart attack, or another blood-clotting disorder before using tranexamic acid. Cyklokapron injection is contraindicated in patients with active intravascular clotting.
Tell your healthcare provider if you use hormonal birth control.
For oral tranexamic acid tablets used for heavy menstrual bleeding, combined hormonal contraceptives are contraindicated because using them together may further increase the risk of blood clots.
Tell your healthcare provider about all prescription medicines, over-the-counter medications, vitamins, and supplements you take.
If you use an anticoagulant or another medication that affects blood clotting, your healthcare provider should determine whether tranexamic acid is appropriate. Do not start, stop, or adjust a blood thinner on your own.
Tranexamic acid is removed from the body mainly through the kidneys. If kidney function is reduced, the medication can build up in the body.
People with kidney impairment may therefore need a lower dose or a longer interval between doses. Kidney impairment itself is not always an absolute reason that tranexamic acid cannot be used.
Tranexamic acid can cause seizures, including focal and generalized seizures.
The risk has been reported most often with high doses used in certain surgical settings or when tranexamic acid is accidentally administered into the spinal canal. Tell your healthcare provider if you have a history of seizures. Dose adjustment may also be important when kidney function is reduced because higher blood levels can increase risk.
Tranexamic acid can occasionally cause visual problems.
Tell your healthcare provider if you develop changes in vision while receiving treatment. The statement that everyone who is color blind must avoid all forms of tranexamic acid is too broad; contraindications and eye-related warnings depend on the specific product labeling.
A previous stroke or blood clot does not automatically mean that every tranexamic acid product is prohibited in every situation. However, a history of thromboembolic disease is an important safety concern because tranexamic acid may increase clotting risk.
Your healthcare provider should review your medical history before treatment and determine whether the benefits outweigh the risks. Active intravascular clotting is specifically contraindicated for injectable tranexamic acid.
Tranexamic acid can cause side effects. The type and frequency depend partly on the formulation being used.
Possible effects may include nausea, vomiting, diarrhea, headache, dizziness, or other gastrointestinal symptoms. Contact your healthcare provider if side effects become severe or persistent.
Get urgent medical attention if you develop symptoms that could suggest a serious blood clot, such as sudden chest pain, difficulty breathing, coughing up blood, sudden weakness or numbness, severe leg pain or swelling, or sudden changes in vision.
These symptoms require prompt medical evaluation.
Serious hypersensitivity reactions, including anaphylactic reactions, have been reported with intravenous tranexamic acid.
Stop treatment and seek immediate medical attention if you develop difficulty breathing, swelling of the face or throat, hives, or another severe allergic reaction.
Tranexamic acid is sometimes used in surgical settings, but the appropriate dose and monitoring depend on the procedure and formulation.
Higher doses and certain surgical settings may increase the risk of seizures or other adverse effects. Patients receiving intravenous tranexamic acid during surgery should be monitored closely, particularly if they have kidney problems or a history of seizures.
Use Cyklokapron or another tranexamic acid product only as directed by your healthcare provider. Tell them about any history of blood clots, stroke, seizures, kidney disease, vision problems, and all medications you take.
Do not increase your dose or continue treatment longer than prescribed, because doing so may increase the risk of serious side effects.
Yes. Tranexamic acid can interact with certain medications, so tell your healthcare provider about all prescription medicines, over-the-counter drugs, vitamins, and supplements you use. For oral tranexamic acid tablets used for heavy menstrual bleeding, combined hormonal contraceptives are contraindicated because using them together may increase the risk of blood clots. If you take a blood thinner or another medicine that affects clotting, your healthcare provider should decide whether tranexamic acid is appropriate for you.
Who should avoid tranexamic acid depends on the specific product and formulation. For oral tranexamic acid tablets used for heavy menstrual bleeding, the medication should not be used by people with an active blood clot, a history or high risk of thrombosis, or certain clotting-related conditions. Combined hormonal contraceptives are also contraindicated with this oral formulation. A history of seizures is not automatically a contraindication, but tranexamic acid can cause seizures in some situations, particularly with high doses or certain intravenous uses. Tell your healthcare provider if you have ever had a seizure.Â
Yes. Oral tranexamic acid tablets are approved to treat cyclic heavy menstrual bleeding. For people with normal kidney function, the usual U.S. dose is 1,300 mg three times daily for up to 5 days during menstruation. This commonly means taking two 650 mg tablets three times a day. The dose may need to be reduced if you have kidney impairment. Do not increase the dose on your own if bleeding remains heavy. Contact your healthcare provider so they can determine whether your treatment needs to be changed or whether another cause of the bleeding should be investigated.
The statement that tranexamic acid must never be used during pregnancy is too broad. Tranexamic acid crosses the placenta, but the appropriate use during pregnancy depends on the reason for treatment, the formulation, and the healthcare provider’s assessment of the benefits and risks. The oral tablets approved for heavy menstrual bleeding are not indicated for use during pregnancy, because they are intended to treat menstrual bleeding. Tell your healthcare provider if you are pregnant, think you may be pregnant, or are planning a pregnancy before using tranexamic acid.
Tranexamic acid can pass into breast milk in small amounts. Available prescribing information reports low concentrations in breast milk after oral treatment. If you are breastfeeding, tell your healthcare provider before using tranexamic acid. They can determine whether treatment is appropriate based on your medical needs and the specific product being used.
No. Tranexamic acid is not considered addictive and does not produce dependence or cravings. It works by slowing the breakdown of blood clots and does not act on the brain’s reward pathways associated with addictive substances. Use it only for the dose and treatment period recommended by your healthcare provider.
| Generic name: | Tranexamic Acid |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 500mg |
| Quantities Available: | 100 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Cyklokapron (tranexamic acid) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Cyklokapron is commonly prescribed in dosages of 500 mg typically taken multiple times per day depending on the condition being treated. For example, if prescribed 1,000 mg (2 tablets) three times daily, then for a 90-day supply you would order 540 tablets (2 tablets x 3 times per day x 90 days).
Yes, we do sell tranexamic acid on our website. You can enjoy competitive prices for this medication. Please note that you will need a valid prescription from your healthcare provider in order to purchase tranexamic acid. We require this to dispense the medication safely. You can submit your prescription by mail, fax, or upload it through your online account for convenience.
Yes, we ship Cyklokapron (tranexamic acid) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Cyklokapron (Tranexamic Acid). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Cyklokapron (Tranexamic Acid).
REVIEWS